- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 314
Blue Water clears $7m
Armed with findings from University of Oxford's Department of Zoology, Blue Water Vaccines believes it has the blueprint for a universal influenza vaccine.
Jul 9, 2019Bolt latches onto series C
Bolt, the ride hailing platform backed by Daimler and Didi Chuxing formerly known as Taxify, has raised a series C round valuing it at more than $1bn.
Jul 9, 2019Evotec reaches Breakpoint with $35m
Evotec has spun out Breakpoint Therapeutics and equipped the oncology drug developer with $35m in funding also backed by Taiho Pharmaceutical.
Jul 9, 2019Anderson Strathern draws up CVC unit
Law firm Anderson Strathern has launched AS Capital to invest in early-stage startups alongside Equity Group, having invested an undisclosed amount in Synaptec.
Jul 9, 2019Exigent legislates fund
The legal outsourcing provider has launched Bright Mind Capital Partners to make early-stage investments in artificial intelligence, blockchain and big data startups.
Jul 8, 2019Broadpeak beams in Eutelsat investment
Eutelsat and the video delivery components developer will partner to expand their portfolio of services for telecom operators, media groups and content providers following the $11.2m investment.
Jul 8, 2019Daily deal net: July 8, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jul 8, 2019Mercia respawns as Mercia Asset Management
Mercia Technologies is now known as Mercia Asset Management, and has announced a $5.1m year-on-year increase in its portfolio value, up from a $3.9m increase in 2017-2018.
Jul 8, 2019PRG acquires Metalysis
Power Resources Group has bought University of Cambridge-founded metal power producer Metalysis, which had plunged into administration last month.
Jul 8, 2019Citryll completes first series A close
Autoimmune disease drug maker Citryll has hit the first close of a targeted $19m series A, having sourced commitments from BrightGene and ModiQuest.
Jul 8, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


